Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep K Mallipattu

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|December 15, 2023
The loss of profilin1 is catastrophic to podocytesSandeep K Mallipattu
Kidney International|November 21, 2025
Mineralocorticoid receptor blockade quiesces parietal epithelial cell activationSandeep K Mallipattu
Kidney Medicine|December 15, 2020
Monitoring Hospitalized Dialysis Patients With COVID-19: Repurposing Baby Monitors for Patient and Staff SafetySobia Khan, Sandeep K Mallipattu
Current Opinion in Nephrology and Hypertension|August 28, 2014
Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?Sandeep K Mallipattu, Jaime Uribarri
Journal of the Endocrine Society|April 2, 2020
The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney DiseaseIgor Kravets, Sandeep K Mallipattu
Kidney International|July 2, 2011
Methotrexate in the urineSandeep K Mallipattu, Michael J Ross
Oncotarget|July 10, 2015
KLF 6: a mitochondrial regulator in the kidneySandeep K Mallipattu, John C He
Pediatric Nephrology (Berlin, Germany)|October 1, 2022
Transcriptional regulation of proximal tubular metabolism in acute kidney injurySian E Piret, Sandeep K Mallipattu
Frontiers in Medicine|April 9, 2015
The beneficial role of retinoids in glomerular diseaseSandeep K Mallipattu, John Cijiang He
American Journal of Physiology. Renal Physiology|April 22, 2016
The podocyte as a direct target for treatment of glomerular disease?Sandeep K Mallipattu, John C He
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|December 15, 2023
The loss of profilin1 is catastrophic to podocytesSandeep K Mallipattu
Kidney International|November 21, 2025
Mineralocorticoid receptor blockade quiesces parietal epithelial cell activationSandeep K Mallipattu
Kidney Medicine|December 15, 2020
Monitoring Hospitalized Dialysis Patients With COVID-19: Repurposing Baby Monitors for Patient and Staff SafetySobia Khan, Sandeep K Mallipattu
Current Opinion in Nephrology and Hypertension|August 28, 2014
Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?Sandeep K Mallipattu, Jaime Uribarri
Journal of the Endocrine Society|April 2, 2020
The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney DiseaseIgor Kravets, Sandeep K Mallipattu
Kidney International|July 2, 2011
Methotrexate in the urineSandeep K Mallipattu, Michael J Ross
Oncotarget|July 10, 2015
KLF 6: a mitochondrial regulator in the kidneySandeep K Mallipattu, John C He
Pediatric Nephrology (Berlin, Germany)|October 1, 2022
Transcriptional regulation of proximal tubular metabolism in acute kidney injurySian E Piret, Sandeep K Mallipattu
Frontiers in Medicine|April 9, 2015
The beneficial role of retinoids in glomerular diseaseSandeep K Mallipattu, John Cijiang He
American Journal of Physiology. Renal Physiology|April 22, 2016
The podocyte as a direct target for treatment of glomerular disease?Sandeep K Mallipattu, John C He
Pageof 8